These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22606696)

  • 1. Cost-effectiveness of fluorescent cystoscopy for noninvasive papillary tumors: con.
    Lotan Y
    J Urol; 2012 May; 187(5):1538-9. PubMed ID: 22606696
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of fluorescent cystoscopy for noninvasive papillary tumors: pro.
    Fradet Y
    J Urol; 2012 May; 187(5):1537-9. PubMed ID: 22425096
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations.
    Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D
    Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence-guided transurethral resection of bladder cancer using hexaminolevulinate: analysis of health economic impact in Sweden.
    Malmström PU; Hedelin H; Thomas YK; Thompson GJ; Durrant H; Furniss J
    Scand J Urol Nephrol; 2009; 43(3):192-8. PubMed ID: 19330681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.
    Witjes JA; Douglass J
    Nat Clin Pract Urol; 2007 Oct; 4(10):542-9. PubMed ID: 17921969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
    Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F
    Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A green light for blue light … without single-dose chemotherapy.
    Griffiths TR; Kockelbergh RC
    Eur Urol; 2014 Nov; 66(5):872-3. PubMed ID: 25063487
    [No Abstract]   [Full Text] [Related]  

  • 8. The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation.
    Garfield SS; Gavaghan MB; Armstrong SO; Jones JS
    Can J Urol; 2013 Apr; 20(2):6682-9. PubMed ID: 23587507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hexaminolevulinate fluorescence cystoscopy in 2009].
    Jacqmin D; Bordier B; Guillotreau J
    Prog Urol; 2010 Mar; 20 Suppl 1():S50-3. PubMed ID: 20493446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["... The better to see you with"--phothodynamic diagnostic in superficial bladder cancer].
    Forster TH; Wyler S; Ruszat R; Gasser TC; Bachmann A
    Praxis (Bern 1994); 2007 Oct; 96(42):1631-7. PubMed ID: 17974123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment.
    Scarpa RM; Cracco CM
    Urology; 2009 Dec; 74(6):1286-7; author reply 1287-8. PubMed ID: 19962530
    [No Abstract]   [Full Text] [Related]  

  • 12. Blue Light Cystoscopy Should be Used Routinely for Bladder Cancer Detection: Pro.
    Steinberg G
    J Urol; 2016 Jun; 195(6):1652-3. PubMed ID: 26995542
    [No Abstract]   [Full Text] [Related]  

  • 13. Blue-sky thinking about blue-light cystoscopy.
    Thomas K; O'Brien T
    BJU Int; 2009 Oct; 104(7):887-9. PubMed ID: 19583718
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
    Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
    J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved detection and reduced early recurrence of non-muscle-invasive bladder cancer using hexaminolaevulinate fluorescence cystoscopy: results of a multicentre prospective randomized study (PC B305).
    Mostafid H; Bunce C;
    BJU Int; 2009 Oct; 104(7):889-90. PubMed ID: 19549121
    [No Abstract]   [Full Text] [Related]  

  • 16. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer--re-TURBT recurrence rates in a prospective, randomized study.
    Geavlete B; Jecu M; Multescu R; Georgescu D; Geavlete P
    Urology; 2010 Sep; 76(3):664-9. PubMed ID: 20627289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over.
    Soria F; Gurioli A; Peraldo F; Oderda M; Giona S; Ambrosini E; Frea B; Gontero P
    Urologia; 2013 Jun; 80 Spec No 1():1-8. PubMed ID: 23813287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden.
    Dansk V; Malmström PU; Bläckberg M; Malmenäs M
    Future Oncol; 2016; 12(8):1025-38. PubMed ID: 26975197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.
    Mark JR; Gelpi-Hammerschmidt F; Trabulsi EJ; Gomella LG
    Can J Urol; 2012 Apr; 19(2):6227-31. PubMed ID: 22512972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On surgical treatment of so-called benign bladder tumors].
    Mebel M; Wilke H
    Z Urol Nephrol; 1966 Sep; 59(9):679-84. PubMed ID: 5997448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.